{"doc_id": "si-2022-0365-reg-1", "parent_doc_id": "si-2022-0365", "section_id": "reg-1", "section_label": "Regulation 1.", "si_number": "S.I. No. 365 of 2022", "title": "Medicines Board (Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the", "year": 2022, "heading": "1. These Regulations may be cited as the In Vitro Diagnostic Medical", "text_raw": "1. These Regulations may be cited as the In Vitro Diagnostic Medical \n\nDevices (Registration) Regulations 2022. \n\nDefinitions", "text_norm": "1 regulation may cited vitro diagnostic medical device (registration) regulation 2022 definition", "start_char": 605, "end_char": 733, "source_path": "downloads\\2022\\2022_0364.pdf", "extraction_method": "pdfminer", "checksum": "sha256:a9ca43f26bdde21ba9ade0bcdc78a09dc07ec733cbc68f4febae558a9fdc4232", "cross_refs": []}
{"doc_id": "si-2022-0365-reg-2", "parent_doc_id": "si-2022-0365", "section_id": "reg-2", "section_label": "Regulation 2.", "si_number": "S.I. No. 365 of 2022", "title": "Medicines Board (Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the", "year": 2022, "heading": "2. (1) In these Regulations—", "text_raw": "2. (1) In these Regulations— \n\n“Authority” means the Health Products Regulatory Authority; \n\n“device” means— \n\n(a) \n(b) \n\nan in vitro diagnostic medical device, \nan accessory for an in vitro diagnostic medical device, \n\nand does not include— \n\n(i) \n\na product or other substance excluded by Article 1(3) of \nthe IVD Medical Devices Regulation, \n\n(ii) an in-house device; \n\n“Directive” means Directive 98/79/EC of the European Parliament and of the \nCouncil of 27 October 19981 as amended by Commission Directive \n2011/100/EU of 20 December 2011;2 \n\n“IVD Medical Devices Regulation” means Regulation (EU) 2017/746 of the \nEuropean Parliament and of the Council of 5 April 20173 as amended by \nRegulation (EU) 2022/112 of the European Parliament and of the Council of 25 \n\n1 OJ No. L331, 7.12.98, p. 1. \n2 OJ No. L341, 22.12.2011, p. 50. \n3 OJ No. L 117, 5.5.2017, p. 176. \n\nNotice of the making of this Statutory Instrument was published in \n“Iris Oifigiúil” of 22nd July, 2022. \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n\f[365] 3 \n\nJanuary 2022;4 \n\n“in-house device” means a device which— \n\n(a) \n\n(b) \n\nis manufactured and used only within a health institution, \n\ncomplies with all of the conditions in Article 5(5) of the IVD \nMedical Devices Regulation, and \n\n(c) \n\nis not manufactured on an industrial scale; \n\n“in vitro diagnostic medical device” has the meaning — \n\n(a) \n\n(b) \n\nassigned to it by Article 2(2) of the IVD Medical Devices \nRegulation, or \n\nassigned to the term “in vitro diagnostic medical device” by \nRegulation 2(1) of the European Communities (In Vitro \nDiagnostic Medical Devices) Regulations 2001 (S.I. No. 304 of \n2001), \n\nas applicable; \n\n“manufacturing facility” means a place where an entity which does not place \ndevices on the market under its own name or under its own trademark— \n\n(a) manufactures a device, \n\n(b) manufactures one or more critical components of a device to a \n\nset of specifications, \n\n(c) \n\ncarries out packaging activities in relation to a device, or \n\n(d) \n\ncarries out labelling activities in relation to a device; \n\n(2) A word or expression which is used in these Regulations, and which \n\nis also used in the IVD Medical Devices Regulation or the Directive, has, \nunless the context otherwise requires, the same meaning in these Regulations \nas it has in the said Regulation or Directive, as applicable. \n\nRegistration requirements in relation to devices", "text_norm": "2 (1) regulations-- authority mean health product regulatory authority device means-- (a) (b) vitro diagnostic medical device accessory vitro diagnostic medical device include-- (i) product substance excluded article 1(3) ivd medical device regulation (ii) in-house device directive mean directive 98 79 ec european parliament council 27 october 19981 amended commission directive 2011 100 eu 20 december 2011 2 ivd medical device regulation mean regulation (eu) 2017 746 european parliament council 5 april 20173 amended regulation (eu) 2022 112 european parliament council 25 1 oj no l331 7.12.98 p 1 2 oj no l341 22.12.2011 p 50 3 oj no l 117 5.5.2017 p 176 notice making statutory instrument published iris oifigiuil 22nd july 2022 365 3 january 2022 4 in-house device mean device which-- (a) (b) manufactured used within health institution complies condition article 5(5) ivd medical device regulation (c) manufactured industrial scale vitro diagnostic medical device meaning -- (a) (b) assigned article 2(2) ivd medical device regulation assigned term vitro diagnostic medical device regulation 2(1) european community (in vitro diagnostic medical devices) regulation 2001 (s.i no 304 2001) applicable manufacturing facility mean place entity place device market name trademark-- (a) manufacture device (b) manufacture one critical component device set specification (c) carry packaging activity relation device (d) carry labelling activity relation device (2) word expression used regulation also used ivd medical device regulation directive unless context otherwise requires meaning regulation said regulation directive applicable registration requirement relation device", "start_char": 733, "end_char": 3129, "source_path": "downloads\\2022\\2022_0364.pdf", "extraction_method": "pdfminer", "checksum": "sha256:a9ca43f26bdde21ba9ade0bcdc78a09dc07ec733cbc68f4febae558a9fdc4232", "cross_refs": []}
{"doc_id": "si-2022-0365-reg-3", "parent_doc_id": "si-2022-0365", "section_id": "reg-3", "section_label": "Regulation 3.", "si_number": "S.I. No. 365 of 2022", "title": "Medicines Board (Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the", "year": 2022, "heading": "3. (1) This Regulation applies to devices placed on the market in the", "text_raw": "3. (1) This Regulation applies to devices placed on the market in the \n\nEuropean Economic Area in accordance with — \n\n(a) \n\nthe IVD Medical Devices Regulation, and \n\n4 OJ No. L 19, 28.1.2022, p. 3. \n\n \n \n \n \n \n \n \n \n \n \n\f4 [365] \n\n(b) \n\nthe Directive pursuant to Article 110(3) of the IVD Medical \nDevices Regulation. \n\n(2) A manufacturer who, having his or her established place of business \n\nin the State, places a device on the market under his or her own name shall, \n\nin the manner prescribed by the Authority— \n\n(a) \n\n(b) \n\nnotify the Authority of his or her name and registered place of \nbusiness, and \n\nsupply the Authority with a description of the device which is \nsufficient to identify it. \n\n(3) A manufacturer who, having designated an authorised representative \nwhich has his or her established place of business in the State, places a device \non the market shall, in the manner prescribed by the Authority— \n\n(a) \n\n(b) \n\n(c) \n\nnotify the Authority of his or her name and registered place of \nbusiness, \n\nsupply the Authority with a description of the device which is \nsufficient to identify it, and \n\nfurnish the Authority with sufficient evidence to establish that \nhe or she has designated his or her authorised representative in \nrespect of the device concerned in accordance with Article 11 of \nthe IVD Medical Devices Regulation or Article 10(3) of the \nDirective, as applicable. \n\n(4) An authorised representative having his or her established place of \n\nbusiness in the State, shall, in the manner prescribed by the Authority— \n\n(a) notify the Authority of his or her name and registered place of \n\nbusiness, \n\n(b) \n\n(c) \n\nsupply the Authority with a description of the device which is \nsufficient to identify it, and \n\nfurnish the Authority with sufficient evidence to establish that \nhe or she has been designated by the manufacturer as his or her \nauthorised representative in respect of the device concerned in \naccordance with Article 11 of the IVD Medical Devices \nRegulation or Article 10(3) of the Directive, as applicable. \n\n(5) An importer who, having his or her established place of business in the \nState, places a device on the market shall, in the manner prescribed by the \nAuthority— \n\n(a) \n\nnotify the Authority of— \n\n(i) \n\nhis or her name and registered place of business, \n\n(ii) \n\nthe name and registered place of business of the \nmanufacturer of the device, and \n\n(b) \n\nsupply the Authority with information relating to the category of \nthe device. \n\n \n \n\f[365] 5 \n\n(6) A distributor who, having his or her established place of business in the \nState, makes a device available on the market shall, in the manner prescribed \nby the Authority— \n\n(a) \n\n(b) \n\nnotify the Authority of his or her name and registered place of \nbusiness, and \n\nsupply the Authority with information relating to the category of \nthe device. \n\nRegistration requirements in relation to health institutions \n\nA health institution in the State which manufactures and uses an in4. \nhouse device within that institution shall, in the manner prescribed by the \nAuthority— \n\n(a) notify the Authority of its name and address, and \n\n(b) \n\nsupply the Authority with information about the in-house device \non request. \n\nRegistration requirements in relation to manufacturing facilities", "text_norm": "3 (1) regulation applies device placed market european economic area accordance -- (a) ivd medical device regulation 4 oj no l 19 28.1.2022 p 3 4 365 (b) directive pursuant article 110(3) ivd medical device regulation (2) manufacturer established place business state place device market name shall manner prescribed authority-- (a) (b) notify authority name registered place business supply authority description device sufficient identify it (3) manufacturer designated authorised representative established place business state place device market shall manner prescribed authority-- (a) (b) (c) notify authority name registered place business supply authority description device sufficient identify furnish authority sufficient evidence establish designated authorised representative respect device concerned accordance article 11 ivd medical device regulation article 10(3) directive applicable (4) authorised representative established place business state shall manner prescribed authority-- (a) notify authority name registered place business (b) (c) supply authority description device sufficient identify furnish authority sufficient evidence establish designated manufacturer authorised representative respect device concerned accordance article 11 ivd medical device regulation article 10(3) directive applicable (5) importer established place business state place device market shall manner prescribed authority-- (a) notify authority of-- (i) name registered place business (ii) name registered place business manufacturer device (b) supply authority information relating category device 365 5 (6) distributor established place business state make device available market shall manner prescribed authority-- (a) (b) notify authority name registered place business supply authority information relating category device registration requirement relation health institution health institution state manufacture us in4 house device within institution shall manner prescribed authority-- (a) notify authority name address (b) supply authority information in-house device request registration requirement relation manufacturing facility", "start_char": 3129, "end_char": 6421, "source_path": "downloads\\2022\\2022_0364.pdf", "extraction_method": "pdfminer", "checksum": "sha256:a9ca43f26bdde21ba9ade0bcdc78a09dc07ec733cbc68f4febae558a9fdc4232", "cross_refs": []}
{"doc_id": "si-2022-0365-reg-5", "parent_doc_id": "si-2022-0365", "section_id": "reg-5", "section_label": "Regulation 5.", "si_number": "S.I. No. 365 of 2022", "title": "Medicines Board (Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the", "year": 2022, "heading": "5. A manufacturing facility in the State shall, in the manner prescribed by", "text_raw": "5. A manufacturing facility in the State shall, in the manner prescribed by \n\nthe Authority— \n\n(a) \n\n(b) \n\nnotify the Authority in writing of the name and address of the \nfacility, and \n\nsupply the Authority with information regarding the activity \nrelating to devices carried out in the facility. \n\nGIVEN under my Official Seal, \n\n14 July, 2022. \n\nSTEPHEN DONNELLY, \nMinister for Health. \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\f6 [365]", "text_norm": "5 manufacturing facility state shall manner prescribed authority-- (a) (b) notify authority writing name address facility supply authority information regarding activity relating device carried facility given official seal 14 july 2022 stephen donnelly minister health 6 365", "start_char": 6421, "end_char": 6861, "source_path": "downloads\\2022\\2022_0364.pdf", "extraction_method": "pdfminer", "checksum": "sha256:a9ca43f26bdde21ba9ade0bcdc78a09dc07ec733cbc68f4febae558a9fdc4232", "cross_refs": []}
{"doc_id": "si-2022-0365-explanatory-note", "parent_doc_id": "si-2022-0365", "section_id": "explanatory-note", "section_label": "EXPLANATORY NOTE", "si_number": "S.I. No. 365 of 2022", "title": "Medicines Board (Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the", "year": 2022, "heading": "(This note is not part of the Instrument and does not purport to be a legal", "text_raw": "EXPLANATORY NOTE \n\n(This note is not part of the Instrument and does not purport to be a legal \ninterpretation.) \n\nThese Regulations are made under section 32 of the Irish Medicines Board Act", "text_norm": "explanatory note (this note part instrument purport legal interpretation.) regulation made section 32 irish medicine board act", "start_char": 6861, "end_char": 7054, "source_path": "downloads\\2022\\2022_0364.pdf", "extraction_method": "pdfminer", "checksum": "sha256:a9ca43f26bdde21ba9ade0bcdc78a09dc07ec733cbc68f4febae558a9fdc4232", "cross_refs": []}
{"doc_id": "si-2022-0365-reg-1995", "parent_doc_id": "si-2022-0365", "section_id": "reg-1995", "section_label": "Regulation 1995.", "si_number": "S.I. No. 365 of 2022", "title": "Medicines Board (Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the", "year": 2022, "heading": "The purpose of these Regulations is to provide for registration requirements in", "text_raw": "1995. \n\nThe purpose of these Regulations is to provide for registration requirements in \nrelation to in vitro diagnostic medical devices placed on the market in the State. \n\nThese Regulations may be cited as the In Vitro Diagnostic Medical Devices \n(Registration) Regulations 2022. \n\n \n \n \n \n \n \n \n\f[365] 7 \n\nBAILE ÁTHA CLIATH \nARNA FHOILSIÚ AG OIFIG AN tSOLÁTHAIR \nLe ceannach díreach ó \nFOILSEACHÁIN RIALTAIS, \nBÓTHAR BHAILE UÍ BHEOLÁIN, \nCILL MHAIGHNEANN, \nBAILE ÁTHA CLIATH 8, \nD08 XAO6 \n\nTeil: 046 942 3100 \nr-phost: publications@opw.ie \n—————— \n\nDUBLIN \nPUBLISHED BY THE STATIONERY OFFICE \nTo be purchased from \nGOVERNMENT PUBLICATIONS, \nMOUNTSHANNON ROAD, \nKILMAINHAM, DUBLIN 8, \nD08 XAO6 \n\nTel: 046 942 3100 \nE-mail: publications@opw.ie \n—————— \n\n€ 3.00 \n\n(DH-430) 75. 7/22. Propylon.", "text_norm": "1995 purpose regulation provide registration requirement relation vitro diagnostic medical device placed market state regulation may cited vitro diagnostic medical device (registration) regulation 2022 365 7 baile atha cliath arna fhoilsiu ag oifig tsolathair le ceannach direach foilseachain rialtais bothar bhaile ui bheolain cill mhaighneann baile atha cliath 8 d08 xao6 teil 046 942 3100 r-phost publication opw.ie ------------ dublin published stationery office purchased government publication mountshannon road kilmainham dublin 8 d08 xao6 tel 046 942 3100 e-mail publication opw.ie ------------ eur 3.00 (dh-430) 75 7 22 propylon", "start_char": 7054, "end_char": 7846, "source_path": "downloads\\2022\\2022_0364.pdf", "extraction_method": "pdfminer", "checksum": "sha256:a9ca43f26bdde21ba9ade0bcdc78a09dc07ec733cbc68f4febae558a9fdc4232", "cross_refs": []}
